GlassScriptPhysician profile
Savannah Halter
NPI 1437923075
$555.95
in general payments reported to CMS, 2019-2025
9 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $37.64 · 2024: $76.64 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.24 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $168.85 | 2024-2025 | Dupixent |
| Kowa Pharmaceuticals America, INC. | $124.34 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $111.56 | 2023-2025 | Nucala |
| Genzyme Corporation | $38.09 | 2025 | |
| Optinose US, INC. | $29.71 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.23 | 2025 | Tezspire |
| Pharming Healthcare, INC. | $23.12 | 2023 | Ruconest |
| Phadia US INC. | $19.65 | 2025 | Immunocap |
| Medtronic, INC. | $17.40 | 2025 | Novapak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Halter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.